Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Press Release on the Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2025.
WOCKPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Wockhardt Limited has submitted its unaudited financial results (both standalone and consolidated) for the third quarter and nine months ending 31st December 2025 to the stock exchanges, as required under Regulation 30 of the Listing Regulations. The detailed numbers and commentary are contained in the press release attached to the filing. This is a standard quarterly disclosure and the first look at the company's financial performance for the October–December 2025 quarter. Investors should review the attached press release for actual revenue, profit, and segment-level details.
This is an intimation of the earnings release rather than the results themselves — no immediate price-moving numbers are visible in the filing text. The actual reaction will depend on whether revenue, profit, and margins beat or miss street expectations when the full press release is reviewed.